Some of these biomarkers, such as CEA and Cyfra21-1, have been applied in the clinical diagnosis of NSCLC according to the National Academy of Clinical Biochemistry guidelines18. The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.